1-7 of 7
Mark Jesus M. Magbanua
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B019: Clinical and molecular correlates of circulating tumor DNA (ctDNA) dynamics in breast tumors resistant to neoadjuvant therapy (NAT)

Mark Jesus M. Magbanua, Denise M. Wolf, Samuel Rivera-Hinojosa, Ziad Ahmed, Nayelis A. Manon, Rosalyn Sayaman, Antony Tin, Ekaterina Kalashnikova, Lamorna Brown Swigart, Gillian L. Hirst, Christina Yau, Wen Li, Claudine Isaacs, Rebecca A. Shatsky, Amy L. Delson, Charuta C. Palsuledesai, Angel Rodriguez, Minetta C. Liu, Paula R. Pohlmann, Laura J. Esserman, Hope S. Rugo, Angela DeMichele, Laura van 't Veer
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B019.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B019
Published: 13 November 2024
View article titled, Abstract B019: Clinical and molecular correlates of circulating tumor DNA (ctDNA) dynamics in breast tumors resistant to neoadjuvant therapy (NAT)
Journal Articles

Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Mark Jesus M. Magbanua, Ziad Ahmed, Rosalyn W. Sayaman, Lamorna Brown Swigart, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Jane Perlmutter, Paula Pohlmann, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela M. DeMichele, Hope S. Rugo, Laura J. van 't Veer
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (11): 2444–2451.
https://doi.org/10.1158/1078-0432.CCR-23-2928
Published: 03 June 2024
View article titled, Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
Open the PDF for Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

Mark Jesus M. Magbanua, Oleksandr Savenkov, Erik J. Asmus, Karla V. Ballman, Janet H. Scott, John W. Park, Maura Dickler, Ann Partridge, Lisa A. Carey, Eric P. Winer, Hope S. Rugo
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4911–4920.
https://doi.org/10.1158/1078-0432.CCR-20-1329
Published: 15 September 2020
View article titled, Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab
Open the PDF for Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab in another window
Includes: Supplementary data
Journal Articles

Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL

Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown-Swigart, A. Jo Chien, Amy L. Delson, Jessica Gibbs, Alexey Aleshin, Bernhard Zimmerman, I-SPY 2 Consortium, Laura Esserman, Nola Hylton, Laura van 't Veer
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A50.
https://doi.org/10.1158/1557-3265.LiqBiop20-A50
Published: 01 June 2020
View article titled, Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL
Journal Articles

Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer

Mark Jesus M. Magbanua, Christina Yau, Denise M. Wolf, Jin Sun Lee, Aheli Chattopadhyay, Janet H. Scott, Erin Bowlby-Yoder, E. Shelley Hwang, Michael Alvarado, Cheryl A. Ewing, Amy L. Delson, Laura J. van't Veer, Laura Esserman, John W. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5388–5397.
https://doi.org/10.1158/1078-0432.CCR-18-3888
Published: 03 September 2019
View article titled, Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer
Open the PDF for Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)

Mark Jesus M. Magbanua, Hope S. Rugo, Denise M. Wolf, Louai Hauranieh, Ritu Roy, Praveen Pendyala, Eduardo V. Sosa, Janet H. Scott, Jin Sun Lee, Brandelyn Pitcher, Terry Hyslop, William T. Barry, Steven J. Isakoff, Maura Dickler, Laura van't Veer, John W. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1486–1499.
https://doi.org/10.1158/1078-0432.CCR-17-2312
Published: 14 March 2018
View article titled, Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)
Open the PDF for Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance) in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers

Mark Jesus M. Magbanua, Lisa A. Carey, Amy DeLuca, Jimmy Hwang, Janet H. Scott, Mothaffar F. Rimawi, Erica L. Mayer, P. Kelly Marcom, Minetta C. Liu, Francisco J. Esteva, John W. Park, Hope S. Rugo
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1098–1105.
https://doi.org/10.1158/1078-0432.CCR-14-1948
Published: 01 March 2015
View article titled, Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers
Open the PDF for Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers in another window
Includes: Supplementary data